Question to the Department of Health and Social Care:

To ask Her Majesty's Government how many courses of (1) antiviral, and (2) monoclonal, antibody treatments for COVID-19 are (a) currently held by NHS England, and (b) secured via new contracts.

In December 2021, we announced the procurement of 4.25 million courses of oral antivirals, in addition to 730,000 courses previously procured. We have also procured 100,008 courses of the neutralising monoclonal antibody, sotrovimab.

The National Health Service has access to other therapeutics, including remdesivir and Ronapreve. We are unable to provide information on the contracted volumes for other antivirals and monoclonal antibodies and the number of courses currently held in England, as this is commercially sensitive. Hospitals and COVID Medicines Delivery Units can order stock as required.